Clinical Trial Update: Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT [Phase 2]

View source ↗

Summary

Phase 2 results evaluating Tc-99m tilmanocept for localization of primary cutaneous Kaposi's sarcoma and mapping of lymphatic drainage using SPECT/CT.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Lymphoseek (tilmanocept)

Snippet

Sponsor: Navidea Biopharmaceuticals | Conditions: Kaposi's Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2016-09-27